4//SEC Filing
RUXIN MICHAEL I 4
Accession 0001493152-22-026504
CIK 0001362703other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 5:44 PM ET
Size
5.7 KB
Accession
0001493152-22-026504
Insider Transaction Report
Form 4
RUXIN MICHAEL I
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-09-16+469,738,712→ 469,738,712 totalExercise: $0.00Exp: 2032-09-16→ Common Stock (469,738,712 underlying)
Footnotes (1)
- [F1]375,790,967 of the stock options will become exercisable upon the filing by the corporation of an S-8 registration statement covering its 2022 Equity Incentive Plan. The remaining 93,947,745 stock options will vest on May 1, 2023.
Documents
Issuer
THERALINK TECHNOLOGIES, INC.
CIK 0001362703
Entity typeother
Related Parties
1- filerCIK 0001249549
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 5:44 PM ET
- Size
- 5.7 KB